Ipca Laboratories Analysis (March) 2026 | Price, Valuation & Outlook

Ipca Laboratories

NSEI:IPCALAB

Rp 1.601,20

+ Rp15,20 (0,96%)

1.601,20 Rp

+Rp15,20 (0,96%)

End-of-day quote: 03/31/2026

Ipca Laboratories Stock Value

According to analysts, the current valuation of NSEI:IPCALAB is Outperform.

Outperform

Ipca Laboratories Company Info

EPS Growth 5Y

8,04%

Market Cap

Rp402,38 B

Long-Term Debt

Rp5,80 B

Annual earnings

05/27/2026 (E)

Dividend

Rp4,00

Dividend Yield

0,25%

Founded

1949

Industry

Health Care

Country

India

Website

Ipca Laboratories

ISIN Number

INE571A01038

Website

http://www.ipca.com

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Rp1.689,00

5.48%

Last Update: 03/31/2026

Analysts: 18

Highest Price Target Rp1.820,00

Average Price Target Rp1.689,00

Lowest Price Target Rp1.350,00

In the last five quarters, Ipca Laboratories’s Price Target has risen from Rp1.273,40 to Rp1.564,37 - a 22,85% increase. Fourteen analysts predict that Ipca Laboratories’s share price will increase in the coming year, reaching Rp1.689,00. This would represent an increase of 5,48%.

Top growth stocks in the health care sector (5Y.)

What does Ipca Laboratories do?

Ipca Laboratories Limited a pharmaceutical company that manufactures and markets formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments. Business Segments The company operates through five segments: Pharmaceuticals, Biotechnology, Consumer Health Products, Chemicals, and Medical Devices segments. Pharmaceuticals This segment includes the development and production of active pharmaceutical ingredients (APIs) and finished dosage forms. This segment underscor...

Ipca Laboratories Limited a pharmaceutical company that manufactures and markets formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments.

Business Segments

The company operates through five segments: Pharmaceuticals, Biotechnology, Consumer Health Products, Chemicals, and Medical Devices segments.

Pharmaceuticals

This segment includes the development and production of active pharmaceutical ingredients (APIs) and finished dosage forms. This segment underscores the company’s dedication to quality and safety in healthcare, aligning with global regulatory standards. With a focus on research-driven initiatives, this segment seeks to address significant health challenges and improve treatment outcomes for a diverse range of medical conditions.

Biotechnology

This segment invests in research and development to harness biological systems for innovative product development. This sector benefits from cutting-edge technology and scientific advancements, ensuring the production of high-quality therapeutics that meet stringent safety standards.

Consumer Health Products

This segment caters to the growing demand for over-the-counter products and dietary supplements. It focuses on preventive healthcare and wellness, providing consumers with effective products that enhance everyday health. The company employs thorough research and consumer feedback to create products that resonate with market trends.

Chemicals

This segment is involved in the manufacturing of specialty chemicals, offering solutions to various industries, including agriculture, textiles, and automotive. By prioritizing innovation, the company delivers products that meet the evolving needs of these sectors while adhering to environmental regulations.

Medical Devices

This segment markets developing cutting-edge technologies that improve healthcare delivery. This segment is characterized by a focus on enhancing patient care through innovation and safety, ensuring that all products comply with international standards.

Business Strategy

The company’s overarching business strategy revolves around innovation, sustainability, and consumer-centricity. Committed to maintaining its leadership position in the industry, the company continuously strives to enhance operational efficiencies and expand its market presence.

One of the primary focuses of the company’s strategy is to foster a culture of innovation. Investing in research and development is at the forefront, enabling the company to stay ahead of industry trends and consumer preferences. This proactive approach allows the company to introduce new products and refine existing offerings based on rigorous scientific research and market analysis.

Products and Services

The company offers an extensive range of products and services across its various operational segments. This diverse portfolio is designed to meet the complex needs of its global customer base.

Pharmaceutical Products: The company pharmaceutical segment includes a wide array of medications prescription and over-the-counter, that address various health conditions. Each product undergoes rigorous clinical trials and complies with strict regulatory standards to ensure efficacy and safety.

Biotechnology Solutions: The company develops biopharmaceuticals and therapies that leverage biological processes. This includes monoclonal antibodies and therapeutic proteins that provide groundbreaking treatment options for patients with severe medical conditions.

Consumer Health Care: The company produces a selection of wellness products, including dietary supplements, vitamins, and consumer health products that empower individuals to take charge of their health. Tailored to meet the growing demand for preventive health solutions, these products focus on maintaining overall well-being.

Specialty Chemicals: The company chemical segment manufactures a variety of specialty chemicals used across several industries. The products include agricultural chemicals, performance materials, and other industrial chemicals that emphasize quality and innovation while adhering to safety standards.

Medical Devices: The company includes the design and manufacture of advanced medical devices for improving healthcare outcomes. Product offerings range from diagnostic tools to surgical instruments, all designed with patient safety and ease of use in mind.

R&D Services: The company provides research and development services intended at partnering with clients in the development of new products. These services extend to formulation development, regulatory support, and clinical testing, enabling customers to bring innovative products to market efficiently.

Geographical Markets

The company serves an expansive geographical market, spanning multiple continents, including North America, Europe, Asia, and emerging markets. This broad market presence allows the company to diversify its revenue streams and mitigate risks associated with economic fluctuations in specific regions.

In North America, the company focuses on providing high-quality pharmaceuticals and consumer health products, catering to an increasingly health-conscious populace. European markets are targeted with advanced biotechnology solutions and specialty chemicals, where innovation and sustainability are of paramount importance.

Seasonality

The company experiences some degree of seasonality in its operations, influenced primarily by market demand fluctuations throughout the year. Certain products, particularly in the consumer health sector, see heightened demand during seasonal transitions, such as flu season or holiday periods when health awareness increases.

Pharmaceutical sales exhibit seasonal patterns, with a spike in prescriptions during specific times of the year. Conversely, the company encounter slower sales periods coinciding with summer vacations or festive seasons, impacting production scheduling and inventory management.

Customers

The company serves a diverse customer base, encompassing various segments and geographic markets. Core customer categories include healthcare professionals, pharmacies, hospitals, and end consumers. By maintaining strong relationships with each segment, the company ensures its products are readily available where they are needed most.

The healthcare professionals, such as doctors and pharmacists, benefit from the company’s extensive portfolio of pharmaceuticals and medical devices. Hospitals, as key stakeholders, rely on the company for critical supplies and innovative solutions that enhance patient care.

In terms of consumer health products, the company reaches end consumers through retail channels and e-commerce platforms, providing easy access to wellness solutions. The company engages with various stakeholders through individualized communication strategies that cater to specific customer needs.

The expansive reach means that the company engages with thousands of customers annually, allowing it to continuously refine its offerings based on feedback and market trends. This customer-centric approach underpins the company’s success and growth trajectory in its endeavors.

Sales and Marketing

The company employs multifaceted sales and marketing strategies designed to optimize customer reach and engagement. A blend of traditional and digital marketing channels is utilized to enhance visibility and strengthen brand loyalty.

The company include digital advertising, social media campaigns, and targeted promotions tailored to various customer segments. The company prioritizes strong online presence to ensure accessibility and facilitate consumer engagement across diverse platforms.

In-person interactions through trade shows, medical conferences, and community outreach initiatives further augment the company’s marketing efforts. Such engagements foster relationships with healthcare professionals, industry peers, and potential customers, creating avenues for feedback and collaboration.

Additionally, the company understands the importance of educational initiatives, conducting workshops and seminars to inform stakeholders about product benefits and best practices. This proactive approach not only builds brand credibility but also reinforces the company’s commitment to improving community health and wellness.

History

Ipca Laboratories Limited was founded in 1949. The company was incorporated in 1949.

Ipca Laboratories Questions and Answers

Which sectors generate sales and which are the top 3 markets?

**Pharmaceutical Sales:** 85% **API (Active Pharmaceutical Ingredients):** 15% **TOP 3 Markets:** 1. **India:** 45% 2. **USA:** 25% 3. **Europe:** 20% Ipca Laboratories Limited generates the majority of its sales from the pharmaceutical industry, particularly through the sale of finish...

At which locations are the company’s products manufactured?

**Production sites of Ipca Laboratories Limited:** Ipca Laboratories Limited mainly produces its products in India. The key production sites include: 1. **Athal, Silvassa** 2. **Ratlam, Madhya Pradesh** 3. **Indore, Madhya Pradesh** 4. **Ankleshwar, Gujarat** 5. **Pithampur, Madhya Pradesh** Thes...

What strategy does Ipca Laboratories pursue for future growth?

**Revenue Growth:** 8.5% (2024) **Profit Growth:** 10.2% (2024) Ipca Laboratories Limited is pursuing a multi-pronged growth strategy to strengthen its market position and explore new business areas. A key element of this strategy is increased investment in research and development to bring inn...

Which raw materials are imported and from which countries?

**Main raw materials:** Active pharmaceutical ingredients (APIs), intermediates, chemical compounds **Countries of origin:** China, Germany, USA, Italy Ipca Laboratories Limited imports a variety of raw materials necessary for the production of their pharmaceutical products. This includes especial...

How strong is the company’s competitive advantage?

**Market share in India:** 4.2% (2023) **R&D expenses:** 6.5% of revenue (2023) **Export share of revenue:** 48% (2023) Ipca Laboratories Limited has a solid competitive advantage based on several factors. Firstly, the company holds a significant market share of 4.2% in the Indian pharmaceu...

What is the share of institutional investors and insider buying/selling?

**Institutional Investor Share:** 35% (estimated, based on the latest available data from 2023) **Insider Buys/Sells:** No significant transactions in the last year (estimated, based on the latest available data from 2023) The institutional investor share in Ipca Laboratories Limited is approximat...

What percentage market share does Ipca Laboratories have?

**Market share of Ipca Laboratories Limited:** 3.5% (estimated for 2025) **Top competitors and their market shares:** 1. **Sun Pharmaceutical Industries Ltd:** 8.2% 2. **Dr. Reddy's Laboratories Ltd:** 7.5% 3. **Cipla Ltd:** 6.8% 4. **Lupin Ltd:** 5.9% 5. **Aurobindo Pharma Ltd:** 5.2% 6. **To...

Is Ipca Laboratories stock currently a good investment?

**Revenue Growth:** 10% (2024) **Profit Growth:** 8% (2024) **Research and Development Ratio:** 6% of revenue (2024) Ipca Laboratories Limited achieved solid revenue growth of 10% in 2024, attributed to strong demand for its pharmaceutical products and successful market expansion. The 8% profit gro...

Does Ipca Laboratories pay a dividend – and how reliable is the payout?

**Dividend Yield:** 0.8% (2024) **Dividend History:** Continuous payout over the last 5 years Ipca Laboratories Limited pays a dividend, with the current dividend yield at around 0.8%. The company has consistently distributed dividends over the past five years, indicating a certain reliability in...

New support ticket

Explore

Ipca Laboratories Stock Value

Ipca Laboratories Company Info

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does Ipca Laboratories do?

Ipca Laboratories Questions and Answers

Offer & Services

Service & Collaboration

Company & Legal

New support ticket

Explore

Ipca Laboratories Stock Value

Ipca Laboratories Company Info

Analyst Price Target The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does Ipca Laboratories do?

Ipca Laboratories Questions and Answers

Offer & Services

Service & Collaboration

Company & Legal

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.